Comparison of stage III mucinous and serous ovarian cancer: a case-control study.
Zeliha Firat CuylanEmine KarabukMurat OzAhmet Taner TuranMehmet M MeydanliSalih TaskinMustafa Erkan SariHanifi SahinSuat C UlukentOzgur AkbayirKemal GungordukTayfun GungorMehmet F KoseAli AyhanPublished in: Journal of ovarian research (2018)
Patients with MOC seem to be 2.3 times more likely to die of their tumors when compared to women with serous EOC.
Keyphrases